Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA). (Q45997955)

From Wikidata

Jump to navigation Jump to search

scientific article published on 23 September 2014

Language	Label	Description	Also known as
English	Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA).	scientific article published on 23 September 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/25158109

Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA). (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/25158109

0 references

allergic bronchopulmonary aspergillosis

0 references

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158109 AND SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Livingstone Chishimba

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158109 AND SRC:MED&resulttype=core&format=json

6 June 2020

Philip Langridge

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158109 AND SRC:MED&resulttype=core&format=json

6 June 2020

Georgina Powell

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158109 AND SRC:MED&resulttype=core&format=json

6 June 2020

David W Denning

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158109 AND SRC:MED&resulttype=core&format=json

6 June 2020

language of work or name

0 references

publication date

23 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/25158109

Journal of Asthma

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158109 AND SRC:MED&resulttype=core&format=json

6 June 2020

52

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158109 AND SRC:MED&resulttype=core&format=json

6 June 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158109 AND SRC:MED&resulttype=core&format=json

6 June 2020

289-295

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158109 AND SRC:MED&resulttype=core&format=json

6 June 2020

An ongoing Confidential Enquiry into asthma deaths in the Eastern Region of the UK, 2001-2003.

1 reference

https://api.crossref.org/works/10.3109/02770903.2014.958853

21 January 2018

Death rates for asthma in English populations 1979-2007: comparison of underlying cause and all certified causes

1 reference

https://api.crossref.org/works/10.3109/02770903.2014.958853

21 January 2018

Clinical, economic, and humanistic burden of asthma in Canada: a systematic review

1 reference

https://api.crossref.org/works/10.3109/02770903.2014.958853

21 January 2018

Period prevalence of allergic bronchopulmonary mycosis in a regional hospital outpatient population in Ireland 1985-88.

1 reference

https://api.crossref.org/works/10.3109/02770903.2014.958853

21 January 2018

Immune response, diagnosis and treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis lung disease

1 reference

https://api.crossref.org/works/10.3109/02770903.2014.958853

21 January 2018

Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study

1 reference

https://api.crossref.org/works/10.3109/02770903.2014.958853

21 January 2018

Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization

1 reference

https://api.crossref.org/works/10.3109/02770903.2014.958853

21 January 2018

Effectiveness of voriconazole in the treatment of Aspergillus fumigatus-associated asthma (EVITA3 study).

1 reference

https://api.crossref.org/works/10.3109/02770903.2014.958853

21 January 2018

Inhaled corticosteroids in COPD and the risk of serious pneumonia

1 reference

https://api.crossref.org/works/10.3109/02770903.2014.958853

21 January 2018

Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide

1 reference

https://api.crossref.org/works/10.3109/02770903.2014.958853

21 January 2018

Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: pharmacokinetics and safety

1 reference

https://api.crossref.org/works/10.3109/02770903.2014.958853

21 January 2018

Use of Nebulized Amphotericin B in the Treatment of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.3109/02770903.2014.958853

21 January 2018

Nebulised corticosteroid and amphotericin B: an alternative treatment for ABPA?

1 reference

https://api.crossref.org/works/10.3109/02770903.2014.958853

21 January 2018

Antifungals in the treatment of allergic bronchopulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.3109/02770903.2014.958853

21 January 2018

Allergic bronchopulmonary aspergillosis in a lung transplant patient successfully treated with nebulized amphotericin

1 reference

https://api.crossref.org/works/10.3109/02770903.2014.958853

21 January 2018

Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: data from a randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3109/02770903.2014.958853

21 January 2018

Aerosolized amphotericin for the treatment of allergic bronchopulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.3109/02770903.2014.958853

21 January 2018

The link between fungi and severe asthma: a summary of the evidence.

1 reference

https://api.crossref.org/works/10.3109/02770903.2014.958853

21 January 2018

Summary of the 2008 BTS/SIGN British Guideline on the management of asthma.

1 reference

https://api.crossref.org/works/10.3109/02770903.2014.958853

21 January 2018

Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3109/02770903.2014.958853

21 January 2018

Aerosolized liposomal Amphotericin B: a potential prophylaxis of invasive pulmonary aspergillosis in immunocompromised patients

1 reference

https://api.crossref.org/works/10.3109/02770903.2014.958853

21 January 2018

Efficacy of nebulised liposomal amphotericin B in the attack and maintenance treatment of ABPA: Figure 1–

1 reference

https://api.crossref.org/works/10.3109/02770903.2014.958853

21 January 2018

Identifiers

10.3109/02770903.2014.958853

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158109 AND SRC:MED&resulttype=core&format=json

6 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158109 AND SRC:MED&resulttype=core&format=json

6 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45997955&oldid=1560120949"